These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

152 related articles for article (PubMed ID: 15580986)

  • 1. ACR classification criteria for systemic lupus erythematosus: complement components.
    Nived O; Sturfelt G
    Lupus; 2004; 13(11):877-9. PubMed ID: 15580986
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Increased C1q, C4 and C3 deposition on platelets in patients with systemic lupus erythematosus--a possible link to venous thrombosis?
    Lood C; Eriksson S; Gullstrand B; Jönsen A; Sturfelt G; Truedsson L; Bengtsson AA
    Lupus; 2012 Nov; 21(13):1423-32. PubMed ID: 22878256
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Anti-C1q antibodies and antiendothelial cell antibodies in systemic lupus erythematosus - relationship with disease activity and renal involvement.
    Oelzner P; Deliyska B; Fünfstück R; Hein G; Herrmann D; Stein G
    Clin Rheumatol; 2003 Oct; 22(4-5):271-8. PubMed ID: 14576989
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Complement-mediated solubilization of immune complexes in systemic lupus erythematosus.
    Sakurai T; Fujita T; Kono I; Kabashima T; Yamane K; Tamura N; Kashiwagi H
    Clin Exp Immunol; 1982 Apr; 48(1):37-42. PubMed ID: 6979449
    [TBL] [Abstract][Full Text] [Related]  

  • 5. [Components of the classical complement pathway in systemic lupus erythematosus].
    Maillet F; Goetz J; Hauptmann G; Clauvel JP; Mery JP; Kahn MF; Kazatchkine M
    Presse Med; 1987 Mar; 16(8):378-82. PubMed ID: 2950498
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Clinical management of patients with systemic lupus erythematosus (SLE) with different C1q-CIC and C3 concentrations.
    Karamehic J; Subasic D; Kasumovic M; Hodzic H; Prljaca-Zecevici L; Tufekcic M; Aganovic-Musinovic I
    Med Arh; 2010; 64(2):75-9. PubMed ID: 20514769
    [TBL] [Abstract][Full Text] [Related]  

  • 7. C-reactive protein and complement components but not other acute-phase reactants discriminate between clinical subsets and organ damage in systemic lupus erythematosus.
    Amezcua-Guerra LM; Springall R; Arrieta-Alvarado AA; Rodríguez V; Rivera-Martinez E; Castillo-Martinez D; Bojalil R
    Clin Lab; 2011; 57(7-8):607-13. PubMed ID: 21888025
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Probable systemic lupus erythematosus with cell-bound complement activation products (CB-CAPS).
    Lamichhane D; Weinstein A
    Lupus; 2016 Aug; 25(9):1050-3. PubMed ID: 26911153
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Relative importance of C4 binding protein in the modulation of the classical pathway C3 convertase in patients with systemic lupus erythematosus.
    Daha MR; Hazevoet HM; Hermans J; van Es LA; Cats A
    Clin Exp Immunol; 1983 Oct; 54(1):248-52. PubMed ID: 6604610
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Analysis of C1q polymorphisms suggests association with systemic lupus erythematosus, serum C1q and CH50 levels and disease severity.
    Martens HA; Zuurman MW; de Lange AH; Nolte IM; van der Steege G; Navis GJ; Kallenberg CG; Seelen MA; Bijl M
    Ann Rheum Dis; 2009 May; 68(5):715-20. PubMed ID: 18504288
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Anti-C1q autoantibodies from systemic lupus erythematosus patients activate the complement system via both the classical and lectin pathways.
    Thanei S; Vanhecke D; Trendelenburg M
    Clin Immunol; 2015 Oct; 160(2):180-7. PubMed ID: 26148903
    [TBL] [Abstract][Full Text] [Related]  

  • 12. A review of the use, evaluations, and criticisms of the preliminary criteria for the classification of systemic lupus erythematosus.
    Canoso JJ; Cohen AS
    Arthritis Rheum; 1979 Aug; 22(8):917-21. PubMed ID: 313796
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Vitamin D deficiency as marker for disease activity and damage in systemic lupus erythematosus: a comparison with anti-dsDNA and anti-C1q.
    Mok CC; Birmingham DJ; Ho LY; Hebert LA; Song H; Rovin BH
    Lupus; 2012 Jan; 21(1):36-42. PubMed ID: 21993384
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Selective complete Clq deficiency associated with systemic lupus erythematosus.
    Steinsson K; McLean RH; Merrow M; Rothfield NF; Weinstein A
    J Rheumatol; 1983 Aug; 10(4):590-4. PubMed ID: 6413687
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Use of serum or buffer-changed EDTA-plasma in a rapid, inexpensive, and easy-to-perform hemolytic complement assay for differential diagnosis of systemic lupus erythematosus and monitoring of patients with the disease.
    Ekdahl KN; Norberg D; Bengtsson AA; Sturfelt G; Nilsson UR; Nilsson B
    Clin Vaccine Immunol; 2007 May; 14(5):549-55. PubMed ID: 17344343
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Classification of Systemic Lupus Erythematosus: Systemic Lupus International Collaborating Clinics Versus American College of Rheumatology Criteria. A Comparative Study of 2,055 Patients From a Real-Life, International Systemic Lupus Erythematosus Cohort.
    Inês L; Silva C; Galindo M; López-Longo FJ; Terroso G; Romão VC; Rúa-Figueroa I; Santos MJ; Pego-Reigosa JM; Nero P; Cerqueira M; Duarte C; Miranda LC; Bernardes M; Gonçalves MJ; Mouriño-Rodriguez C; Araújo F; Raposo A; Barcelos A; Couto M; Abreu P; Otón-Sanchez T; Macieira C; Ramos F; Branco JC; Silva JA; Canhão H; Calvo-Alén J; ;
    Arthritis Care Res (Hoboken); 2015 Aug; 67(8):1180-5. PubMed ID: 25581417
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Defining lupus cases for clinical studies: the Boston weighted criteria for the classification of systemic lupus erythematosus.
    Costenbader KH; Karlson EW; Mandl LA
    J Rheumatol; 2002 Dec; 29(12):2545-50. PubMed ID: 12465149
    [TBL] [Abstract][Full Text] [Related]  

  • 18. The complement system in systemic lupus erythematosus: an update.
    Leffler J; Bengtsson AA; Blom AM
    Ann Rheum Dis; 2014 Sep; 73(9):1601-6. PubMed ID: 24845390
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Mechanisms of Disease: the complement system and the pathogenesis of systemic lupus erythematosus.
    Cook HT; Botto M
    Nat Clin Pract Rheumatol; 2006 Jun; 2(6):330-7. PubMed ID: 16932712
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Evidence for complement activation via the alternate pathway in skin diseases, I. Herpes gestationis, systemic lupus erythematosus, and bullous pemphigoid.
    Provost TT; Tomasi TB
    J Clin Invest; 1973 Jul; 52(7):1779-87. PubMed ID: 4352464
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 8.